An investigation into the acute effects of -Epigallocatechin Gallate (EGCG) on cognition, stress, brain function and cardiovascular function in healthy adults.

Swinburne University0 个研究点目标入组 32 人开始时间: 2009年7月30日最近更新: 2020年11月9日

试验速览

暂无简介。

•Healthy non smoking
•- English speaking and right handed
•- No history of anxiety, depression, epilepsy or psychiatric disorders
•- Not taking any medications, for example anti-coagulants, anti-depressants, anti-cholinergics or acetycholinesterase inhibitors
•- Not regularly taking any herbal extracts or vitamin supplements
•- Not taking illicit drugs
•- Possess no health conditions that would affect food metabolism including the following: food allergies, kidney disease, liver disease and/or gastrointestinal diseases (e.g Irritable bowel syndrome, celiac disease, peptic ulcers)
•- Not pregnant or currently breast feeding
•- Willing to participate in two 7 hour session in accordance to protocol
•- Provide a signed and dated informed consent form

•- Currently consume green tea on a daily basis
•- Consume more than 3 standard alcoholic drinks per day
•- Have a habitual caffeine intake exceeding 300mg (>3-4 cups of coffee per day)
•- Have a known allergy to green tea and/or EGCG
•- A history or diagnosis of hypotension, hypertension or heart disease
•- A history of anxiety, depression, epilepsy or psychiatric disorders
•- Currently taking any medications, herbal extracts, vitamin supplements or illicit drugs
•- Any health conditions including celiac disease that would effect food metabolism including the following: food allergies, kidney disease, liver disease and/or gastrointestinal diseases (e.g. Irritable bowel syndrome, peptic ulcers)
•- Pregnancy or breast feeding
•- Current study participation in other trials involving investigational or marketed products

发起方

Swinburne University